97 related articles for article (PubMed ID: 17118797)
1. Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders.
Hoyer D; Thakker DR; Natt F; Maier R; Huesken D; Müller M; Flor P; VAN DER Putten H; Schmutz M; Bilbe G; Cryan JF
J Recept Signal Transduct Res; 2006; 26(5-6):527-47. PubMed ID: 17118797
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.
Thakker DR; Natt F; Hüsken D; Maier R; Müller M; van der Putten H; Hoyer D; Cryan JF
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17270-5. PubMed ID: 15569935
[TBL] [Abstract][Full Text] [Related]
3. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain.
Thakker DR; Natt F; Hüsken D; van der Putten H; Maier R; Hoyer D; Cryan JF
Mol Psychiatry; 2005 Aug; 10(8):782-9, 714. PubMed ID: 15940298
[TBL] [Abstract][Full Text] [Related]
4. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.
Salahpour A; Medvedev IO; Beaulieu JM; Gainetdinov RR; Caron MG
Biol Psychiatry; 2007 Jan; 61(1):65-9. PubMed ID: 16712807
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
Ribeiro P; Patocka N
Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
[TBL] [Abstract][Full Text] [Related]
6. Emerging use of non-viral RNA interference in the brain.
Cryan JF; Thakker DR; Hoyer D
Biochem Soc Trans; 2007 Apr; 35(Pt 2):411-5. PubMed ID: 17371288
[TBL] [Abstract][Full Text] [Related]
7. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
Kindlundh-Högberg AM; Schiöth HB; Svenningsson P
Neurotoxicology; 2007 Nov; 28(6):1158-69. PubMed ID: 17692920
[TBL] [Abstract][Full Text] [Related]
8. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders.
Murphy DL; Uhl GR; Holmes A; Ren-Patterson R; Hall FS; Sora I; Detera-Wadleigh S; Lesch KP
Genes Brain Behav; 2003 Dec; 2(6):350-64. PubMed ID: 14653307
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
10. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.
Ferrés-Coy A; Galofré M; Pilar-Cuéllar F; Vidal R; Paz V; Ruiz-Bronchal E; Campa L; Pazos Á; Caso JR; Leza JC; Alvarado G; Montefeltro A; Valdizán EM; Artigas F; Bortolozzi A
Mol Psychiatry; 2016 Mar; 21(3):328-38. PubMed ID: 26100539
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome.
Jijun L; Zaiwang L; Anyuan L; Shuzhen W; Fanghua Q; Lin Z; Hong L
Neurol India; 2010; 58(4):523-9. PubMed ID: 20739786
[TBL] [Abstract][Full Text] [Related]
13. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain.
Van den Haute C; Eggermont K; Nuttin B; Debyser Z; Baekelandt V
Hum Gene Ther; 2003 Dec; 14(18):1799-807. PubMed ID: 14670130
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine transporter (NET) knock-out upregulates dopamine and serotonin transporters in the mouse brain.
Solich J; Faron-Gorecka A; Kusmider M; Palach P; Gaska M; Dziedzicka-Wasylewska M
Neurochem Int; 2011 Aug; 59(2):185-91. PubMed ID: 21693154
[TBL] [Abstract][Full Text] [Related]
16. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Siebert GA; Pond SM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
18. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
[TBL] [Abstract][Full Text] [Related]
19. Targeted gene expression in dopamine and serotonin neurons of the mouse brain.
Zhuang X; Masson J; Gingrich JA; Rayport S; Hen R
J Neurosci Methods; 2005 Apr; 143(1):27-32. PubMed ID: 15763133
[TBL] [Abstract][Full Text] [Related]
20. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
